A universal influenza vaccine - so-called because it could potentially provide protection from all flu strains for decades - may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

H1N1 Influenza Public Health Emergency Determination to Expire on June 23

Per the FDA-issued advance notice letters listed below, the declaration of Public Health Emergency determination for 2009 H1N1 Influenza expires on June 23, 2010.

A test developed by the U.S. Centers for Disease Control and Prevention to diagnose human infections with the 2009 H1N1 influenza virus (formerly known as swine flu or pandemic H1N1 flu) was authorized for use today by the U.S. Food and Drug Administration.

As of 13 June, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18172 deaths.

The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as Generic Tamiflu sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu’s active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.

Centers for Disease Control and Prevention document that summarizes key events of the 2009 H1N1 pandemic and CDC's response activities.

Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

A global update was provided to the Committee on the pandemic situation, including a particular focus on developments in Africa and the Southern Hemisphere.

Guillain-Barre syndrome (GBS) is an uncommon peripheral neuropathy causing paralysis and in severe cases respiratory failure and death.

The U.S. Food and Drug Administration today announced it has cleared the Simplexa Influenza A H1N1 (2009), a test for the 2009 H1N1 Influenza Virus in patients with signs and symptoms of respiratory infection.

During week 19 ( May 9 - 15, 2010), influenza activity decreased in the U.S.

As of 9 May, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18036 deaths.

Interim results show that compared with the previous flu season, the 2009-10 flu season saw a 67% increase in estimated vaccine coverage for children and a 30% increase for adults aged 18--49 years without high-risk conditions.

As of 25th of April, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 17919 deaths.

As of 18 April 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 17853 deaths.

This document provides updated information on pregnancy as a risk factor for serious 2009 H1N1-related complications based on findings from a recent study.

As of 11 April 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 17798 deaths.

Experts Begin their Assessment of the Response to the H1N1 Influenza Pandemic

As of 4 April 2010, worldwide more than 213 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 17700 deaths